4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0000950170-24-137960
President and CEO sold 100,000 shares at $5.00 ($500,000)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Sanjiv President and CEO | 2024-12-16 | Sale 10b5-1 | −100,000 | $5.00 | $500,000 | 574,548 | I: show line 1 in the form |
| Open-market sales · 100,000 sh · avg $5.00 · $500,000 | |||||||
Loading xslF345X05/ownership.xml…